SCHEMBL830375

SCHEMBL830375

COc1ccc(/C=C/C(=O)CS(=O)(=O)c2cc3cc(Br)ccc3sc2=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.46
PIM3 Q86V86 2/20 0.46
PIM2 Q9P1W9 2/20 0.46
GSK3B P49841 1/20 0.44
POLB P06746 3/20 0.44
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
LMNA P02545 1/20 0.44
HSP90AA1 P07900 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAOA P21397 2/20 0.42
MAOB P27338 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
RECQL P46063 1/20 0.42
BLM P54132 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL830376 1.00 PIM1 (0.46) PIM1PIM3PIM2GSK3BPOLB
SCHEMBL830426 1.00 PIM1 (0.46) PIM1PIM3PIM2GSK3BPOLB
SCHEMBL830946 0.89 MAPT (0.44) GSK3BALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL831052 0.89 MAPT (0.44) GSK3BALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL830512 0.89 GSK3B (0.44) GSK3BALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL829883 0.89 GSK3B (0.44) GSK3BALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL830947 0.89 MAPT (0.44) GSK3BALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL829882 0.89 GSK3B (0.44) GSK3BALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL830010 0.86 GSK3B (0.48) GSK3BALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL831737 0.86 GSK3B (0.48) GSK3BALDH1A1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143428-B2 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-03-27 US claimed
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-10-04 US claimed
EP-1765804-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF Temple University of the Commonwealth System of Higher Education (US) 2007-03-28 EP claimed
WO-2005123077-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-12-29 WO claimed
US-8143428-B2 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-03-27 US disclosed
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof SULT1E1, STS, CCNE1 PIM1 238/4885PIM3 276/4885PIM2 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.